Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- NIH Offers Assistance to Active Phase I HHS SBIR and STTR Awardees through the Niche Assessment Program 2018-2019
National Institutes of Health - Notice of Early Expiration of PAR-17-020 "Limited Competition: Revision Requests for Active Alzheimer's Disease Research Centers (P50)"
National Institute on Aging - NIAID, NIDA, and ORIP Interest in Administrative Supplements to Address the Research and Resources Needed to Develop Vaccines Targeting Opioids
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs - Notice of Webinar and FAQs for NIAID Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required) and Leadership Group for an Infectious Diseases Clinical Research Consortium (IDCRC) (UM1 Clinical Trial Required), RFA-AI-18-046 and RFA-AI-18-047
National Institute of Allergy and Infectious Diseases - Notice of Participation of the National Center for Complementary and Integrative Health (NCCIH) in PA-18-876 "Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed)"
National Center for Complementary and Integrative Health - Notice To Clarify that Support of Competitive Research (SCORE) Awards are Eligible for Support through PA-18-936 "NIH Administrative Supplements to Recover Losses due to Hurricanes Harvey, Irma, and Maria Under the Bipartisan Budget Act of 2018"
National Institute of General Medical Sciences - Notice of NIMH Changes to the RDoC Matrix: Scope and Limitations of NIMH Support of the New Sensorimotor Domain
National Institute of Mental Health - Notice of Intent to Publish the Reissuance of PAR-16-042 Drug Discovery For Nervous System Disorders (R21 Clinical Trial Not Allowed)
National Institute of Mental Health
National Institute on Aging
National Institute on Drug Abuse - Notice of Intent to Publish the Reissuance of PAR-16-041 Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed)
National Institute of Mental Health
National Institute on Aging
National Institute on Drug Abuse - Notice of Change in the Expiration Date for PAR-18-894, " Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed) "
National Institute of Mental Health - Notice to Extend the Expiration Date for PAR-18-139 "Innovative Questions in Symptom Science and Genomics (R01 Clinical Trial Optional)"
National Institute of Nursing Research - Notice to Extend the Expiration Date for PA-18-157 "Innovative Questions in Symptom Science and Genomics (R21 Clinical Trial Optional)"
National Institute of Nursing Research - Notice to Extend the Expiration Date for PA-18-140 "Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R01 Clinical Trial Optional)"
National Institute of Nursing Research - Notice to Extend the Expiration Date for PAR-18-158 "Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R21 Clinical Trial Optional)"
National Institute of Nursing Research - Notice to Encourage Eligible NINDS Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) Initiative Awardees to Apply for PA-18-906 "Research Supplements to Promote Diversity in Health-Related Research"
National Institute of Neurological Disorders and Stroke
Requests for Applications
- Fc-Dependent Mechanisms of Antibody-Mediated Killing (U01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Vaccine and Treatment Evaluation Units (VTEUs) (UM1 Clinical Trial Required)
National Institute of Allergy and Infectious Diseases
- Leadership Group for an Infectious Diseases Clinical Research Consortium (IDCRC) (UM1 Clinical Trial Required)
National Institute of Allergy and Infectious Diseases
- National Dental Practice-Based Research Network: Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Optional)
National Institute of Dental and Craniofacial Research
- Dysregulation and Proximal Risk for Suicide (R21 Clinical Trial Optional)
- Dysregulation and Proximal Risk for Suicide FOA (R01 Clinical Trial Optional)
National Institute of Mental Health
- NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Mental Health
Office of Behavioral and Social Science Research
- Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research (BSSR) - Institutional Research Training Program [T32]
National Institutes of Health
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
National Library of Medicine
Program Announcements
- Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)
National Institutes of Health
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
- Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional)
- Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional)
National Institute of Nursing Research
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Office of Behavioral and Social Science Research
- Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional)
- Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional)
National Institute of Nursing Research
National Center for Complementary and Integrative Health
National Cancer Institute
Office of Behavioral and Social Science Research
- Fc-Dependent Mechanisms of Antibody-Mediated Killing (R21 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)
- Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Dietary Supplements
Office of Research on Women's Health
- Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
- Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
National Center for Advancing Translational Sciences
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- State and Territory Produce Safety Implementation Program Expansion for Entrance into Competition B of PAR-16-137 (U18)
This opportunity is available only to state/territory government food agencies with actual or potential regulatory oversight and responsibility over their respective jurisdiction’s commodities regulated in FDA's “Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption” rule. Only one application is allowed per state/territory.
Food and Drug Administration
- Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R01 Clinical Trial Not Allowed)
- Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21 Clinical Trial Not Allowed)
National Institute on Minority Health and Health Disparities
National Cancer Institute
Details, including application deadlines, when applicable, are available through the program links above. To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Paul Below at paul-below@uiowa.edu, or Lynn Hudachek at lynn-hudachek @uiowa.edu, or Erin Brothers at erin-brothers@uiowa.edu.